The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms
Open accessAbstract
Doxorubicin (DOX), a widely used chemotherapeutic agent, exhibits cardiotoxicity as an adverse side effect in cancer patients. DOX-mediated cardiomyopathy is linked to its ability to induce apoptosis in endothelial cells and cardiomyocytes by activation of p53 protein and reactive oxygen species. We evaluated the potential roles of H(2)O(2) and p53 in DOX-induced apoptosis in normal bovine aortic endothelial cells and adult rat cardiomyocytes and in tumor cell lines PA-1 (human ovarian teratocarcinoma) and MCF-7 (human breast adenocarcinoma). Time course measurements indicated that activation of caspase-3 preceded the stimulation of p53 transcriptional activity in endothelial cells. In contrast, DOX caused early activation of p53 in tumor cells that was followed by caspase-3 activation and DNA fragmentation. These findings suggest that the transcriptional activation of p53 in DOX-induced apoptosis in endothelial cells may not be as crucial as it is in tumor cells. Further evidence was obtained using a p53 inhibitor, pifithrin-alpha. Pifithrin-alpha completely suppressed DOX-induced activation of p53 in both normal and tumor cell lines and prevented apoptosis in tumor cell lines but not in endothelial cells and cardiomyocytes. In contrast, detoxification of H(2)O(2), either by redox-active metalloporphyrin or overexpression of glutathione peroxidase, decreased DOX-induced apoptosis in endothelial cells and cardiomyocytes but not in tumor cells. This newly discovered mechanistic difference in DOX-induced apoptotic cell death in normal versus tumor cells will be useful in developing drugs that selectively mitigate the toxic side effects of DOX without affecting its antitumor action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Doxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 726
Redox regulation of transcriptional activators
Sun, Y., & Oberley, L. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00109-8 · Cited by 692
Kotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003890200 · Cited by 372
Self-citationMcCurrach, M. E., Connor, T. M. F., Knudson, C. M., Korsmeyer, S. J., & Lowe, S. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2345 · Cited by 369
Wu, H., & Lozano, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32128-2 · Cited by 361
Kalyanaraman, B., Perez-Reyes, E., & Mason, R. P. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90142-7 · Cited by 317
Self-citationCulmsee, C., Zhu, X., Yu, Q.-S., Chan, S. L., Camandola, S., Guo, Z., Greig, N. H., & Mattson, M. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00220.x · Cited by 313
Early and delayed clinical cardiotoxicity of doxorubicin
Buzdar, A. U., Marcus, C., Blumenschein, G. R., & Smith, T. L. (1985) · Cancer · doi:10.1002/1097-0142(19850615)55:12<2761::aid-cncr2820551206>3.0.co;2-p · Cited by 300
Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I
Wang, L., Ma, W., Markovich, R., Chen, J.-W., & Wang, P. H. (1998) · Circulation Research · doi:10.1161/01.res.83.5.516 · Cited by 287
WANG, S., KOTAMRAJU, S., KONOREV, E., KALIVENDI, S., JOSEPH, J., & KALYANARAMAN, B. (2002) · Biochemical Journal · doi:10.1042/bj20020752 · Cited by 286
Self-citationFas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats: In Vivo Study
Nakamura, T., Ueda, Y., Juan, Y., Katsuda, S., Takahashi, H., & Koh, E. (2000) · Circulation · doi:10.1161/01.cir.102.5.572 · Cited by 223
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
Anthoney, A., McIlwrath, A. J., Gallagher, W. M., Edlin, A., & Brown, R. E. (1996) · PubMed · Cited by 210
Daunorubicin-Induced Apoptosis in Rat Cardiac Myocytes Is Inhibited by Dexrazoxane
Sawyer, D. B., Fukazawa, R., Arstall, M. A., & Kelly, R. A. (1999) · Circulation Research · doi:10.1161/01.res.84.3.257 · Cited by 207
Signaling pathways activated by daunorubicin
Laurent, G., & Jaffrézou, J.-P. (2001) · Blood · doi:10.1182/blood.v98.4.913 · Cited by 187
Shacter, E., Williams, J. A., Hinson, R. M., Sentürker, S., & Lee, Y.-J. (2000) · Blood · doi:10.1182/blood.v96.1.307 · Cited by 169
Pise-Masison, C. A., Mahieux, R., Jiang, H., Ashcroft, M. A., Radonovich, M. F., Duvall, J. F., Guillerm, C., & Brady, J. N. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3377-3386.2000 · Cited by 158
Lorenzo, E., Ruiz‐Ruiz, C., Quesada, A. J., Hernández, G., Rodríguez, A., López‐Rivas, A., & Redondo, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107442200 · Cited by 157
Gouazé‐Andersson, V., Mirault, M.-É., Carpentier, S., Salvayre, R., Levade, T., & Andrieu‐Abadie, N. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12610-7 · Cited by 153
Sinha, B. K., Mimnaugh, E. G., Rajagopalan, S., & Myers, C. E. (1989) · PubMed · Cited by 152
Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells
Ubezio, P., & Civoli, F. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90129-5 · Cited by 150
Lotem, J., Peled-Kamar, M., Groner, Y., & Sachs, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9166 · Cited by 137
Li, Q., Şanlıoğlu, S., Li, S., Ritchie, T., Oberley, L. W., & Engelhardt, J. F. (2001) · Antioxidants and Redox Signaling · doi:10.1089/15230860152409068 · Cited by 98
Benzo[a]pyrene Activates the Human p53 Gene through Induction of Nuclear Factor κB Activity
Pei, X., Nakanishi, Y., Takayama, K., Bai, F., & Hara, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35240 · Cited by 90
Komarova, E. A., & Gudkov, A. V. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00733-x · Cited by 81
Bichât, F., Bras-Gonçalves, R., Miccoli, L., Dutrillaux, B., & Poupon, M. (2000) · PubMed · Cited by 81
Konorev, E. A., Kotamraju, S., Zhao, H., Kalivendi, S. V., Joseph, J., & Kalyanaraman, B. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00989-9 · Cited by 63
Self-citationInduction of Apoptosis by Chemotherapeutic Drugs without Generation of Reactive Oxygen Species
Sentürker, S., Tschirret-Guth, R. A., Morrow, J. D., Levine, R. L., & Shacter, E. B. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2681 · Cited by 59
Kwok, J. C., & Richardson, D. R. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.888 · Cited by 54
Havre, P. A., O’Reilly, S., McCormick, J. J., & Brash, D. E. (2002) · PubMed · Cited by 53
da Costa, C. A., Mattson, M. P., Ancolio, K., & Checler, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212379200 · Cited by 53
Alaparthy, S., Guédez, L., Moreb, J. S., & Zucali, J. R. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04074.x · Cited by 36
Konorev, E. A., Zhang, H., Joseph, J., Kennedy, M. C., & Kalyanaraman, B. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2424 · Cited by 14
Self-citationNF-κB prevents cells from undergoing Cr(VI)-induced apoptosis
Wang, S., Chen, F., Zhang, Z., Shi, X., Jiang, B., & Luo, J. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007269.74532.98 · Cited by 12
Self-citation
Cited by
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
Lubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280
Doxorubicin, DNA torsion, and chromatin dynamics
Yang, F., Teves, S. S., Kemp, C. J., & Henikoff, S. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.002 · Cited by 695
Oxidative Stress in Cancer Cell Metabolism
Arfin, S., Jha, N. K., Jha, S. K., Kesari, K. K., Ruokolainen, J., Roychoudhury, S., Rathi, B., & Kumar, D. (2021) · Antioxidants · doi:10.3390/antiox10050642 · Cited by 665
Ye, D., Shuhendler, A. J., Cui, L., Tong, L., Tee, S. S., Tikhomirov, G., Felsher, D. W., & Rao, J. (2014) · Nature Chemistry · doi:10.1038/nchem.1920 · Cited by 492
Metadata
- Authors
- Wang, S., Konorev, E. A., Kotamraju, S., Joseph, J., Kalivendi, S., & Kalyanaraman, B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 24
- Pages
- 25535-25543
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1968351069
- Cited by
- 611
- References
- 41
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.